Hydroxocobalamin in Refractory Vasodilatory Shock: More Questions than Answers
J Cardiothorac Vasc Anesth
.
2023 Sep;37(9):1773-1775.
doi: 10.1053/j.jvca.2023.05.001.
Epub 2023 May 6.
Authors
Nicolas Kumar
1
,
Grace R Rahman
2
,
Samuel Falkson
1
,
Shu Yang Lu
1
,
Adam Dalia
1
Affiliations
1
Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
2
University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.
PMID:
37225547
DOI:
10.1053/j.jvca.2023.05.001
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Hydroxocobalamin / adverse effects
Hypotension*
Shock* / drug therapy
Vasoconstrictor Agents / therapeutic use
Vasodilation
Substances
Hydroxocobalamin
Vasoconstrictor Agents